Log in to save to my catalogue

Therapeutic Potential of Cannabinoids in Glaucoma

Therapeutic Potential of Cannabinoids in Glaucoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_591eacb01d7c4c699a8851d42d0901f5

Therapeutic Potential of Cannabinoids in Glaucoma

About this item

Full title

Therapeutic Potential of Cannabinoids in Glaucoma

Publisher

Basel: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2023-08, Vol.16 (8), p.1149

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Glaucoma is a leading cause of irreversible blindness worldwide. To date, intraocular pressure (IOP) is the only modifiable risk factor in glaucoma treatment, but even in treated patients, the disease can progress. Cannabinoids, which have been known to lower IOP since the 1970s, have been shown to have beneficial effects in glaucoma patients beyon...

Alternative Titles

Full title

Therapeutic Potential of Cannabinoids in Glaucoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_591eacb01d7c4c699a8851d42d0901f5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_591eacb01d7c4c699a8851d42d0901f5

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph16081149

How to access this item